Tell me about BBLG

Bone Biologics Corporation (BBLG) is a medical device company focused on bone regeneration in spinal fusion. Here's an analysis of the company:

1. **Financial Metrics**:
- The company's P/E ratio is 1.36, indicating that investors are willing to pay $1.36 for every dollar of earnings.
- BBLG's P/S ratio is not available.
- The stock has a negative P/E(TTM) of -0.64, suggesting that the company is not currently profitable.

2. **Technical Indicators**:
- The MACD is at 0.22, which could indicate a potential upward trend.
- The RSI is at 65.23, suggesting that the stock is neither overbought nor oversold.
- The KDJ indicator is at 90.9, which is typically considered an overbought condition.
- The stock's 52-week low was at $1.00, and it has a current price of $2.08, indicating a significant recovery.

3. **Market Performance and Sentiment**:
- BBLG has experienced a substantial increase in its stock price, rising by 26.07% to $2.74.
- The company has a heavy trading volume, which could be indicative of market interest or volatility.
- BBLG has a beta of 0.31, suggesting that its stock price is less volatile than the S&P 500.
4. **Industry and Product Focus**:
- BBLG operates in the health care equipment & supplies industry.
- The company's core technology, UCB-1™, is designed to facilitate bone growth, and its product, NELL-1/DBM Fusion Device, is intended for spinal fusion procedures.
5. **Recent Company Developments**:
- BBLG has appointed a new board member, Robert E. Gagnon, and plans to present at the H.C. Wainwright 26th Annual Global Investment Conference.
- The company has exercised warrants for the purchase of common stock, raising approximately $2.1 million.
6. **Challenges and Opportunities**:
- BBLG has faced challenges, including a significant downturn in its stock value over the past year and negative earnings.
- The company's future performance will depend on its ability to overcome these challenges and capitalize on opportunities in the regenerative medicine space.

In conclusion, BBLG is a medical device company with a focus on bone regeneration, currently experiencing a recovery in its stock price and market sentiment. However, it still faces challenges in terms of profitability and volatility, which could impact its future performance.